BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36276947)

  • 1. Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy.
    Li Z; Duan Y; Ke Q; Wang M; Cen H; Zhu X
    Front Genet; 2022; 13():1000460. PubMed ID: 36276947
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
    He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
    J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
    Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
    Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma.
    Xiong D; Wei X; Huang W; Zheng J; Feng R
    Aging (Albany NY); 2024 Jan; 16(2):1049-1076. PubMed ID: 38240686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal Carcinoma Subtype Discovery via Immune Cell Scores from Tumor Microenvironment.
    Sun Y; Liu Y; Chu H
    J Immunol Res; 2023; 2023():2242577. PubMed ID: 37274867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrative analysis of a necroptosis-related gene signature of clinical value and heterogeneity in diffuse large B cell lymphoma.
    Pan YB; Wang W; Cai HK; Zhang J; Teng Y; Xue J; Zhu M; Luo WD
    Front Genet; 2022; 13():911443. PubMed ID: 36035126
    [No Abstract]   [Full Text] [Related]  

  • 9. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
    Chen X; Hu S; Han Y; Cai Y; Lu T; Hu X; Chu Y; Zhou X; Wang X
    Clin Exp Med; 2023 Oct; 23(6):2601-2617. PubMed ID: 36682001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glycolysis-related gene signatures in diffuse large B-Cell lymphoma predicts prognosis and tumor immune microenvironment.
    Cui Y; Leng C
    Front Cell Dev Biol; 2023; 11():1070777. PubMed ID: 36755971
    [No Abstract]   [Full Text] [Related]  

  • 11. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
    Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
    J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.
    Li Y; Liu X; Chang Y; Fan B; Shangguan C; Chen H; Zhang L
    Biomed Res Int; 2022; 2022():2645090. PubMed ID: 36281462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-related tumor environment correlated with immune infiltration and therapeutic sensitivity in diffuse large B-cell lymphoma.
    Liu C; Liu L
    Front Genet; 2022; 13():1037716. PubMed ID: 36313435
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma.
    Zhang Z; Zhao C; Yang S; Lu W; Shi J
    Lipids Health Dis; 2024 Jan; 23(1):20. PubMed ID: 38254162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals dynamic candidate genes and signaling pathways involved in the progression and prognosis of diffuse large B-cell lymphoma.
    Charwudzi A; Meng Y; Hu L; Ding C; Pu L; Li Q; Xu M; Zhai Z; Xiong S
    PeerJ; 2021; 9():e12394. PubMed ID: 34760386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma.
    Zhang W; Shi JN; Wang HN; Zhang T; Zhou X; Zhang HM; Zhu F
    Ann Transl Med; 2022 Dec; 10(24):1323. PubMed ID: 36660618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Aging-Related Genes Associated with Prognostic Value and Immune Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma.
    Luo C; Nie H; Yu L
    Oxid Med Cell Longev; 2022; 2022():3334522. PubMed ID: 35069971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells.
    Qi J; Xu L; Huang D; He H; Yao J; Zhang J; Xu Y; Yang L
    J Oncol; 2022; 2022():3168172. PubMed ID: 35237321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic gene model of immune cell infiltration in diffuse large B-cell lymphoma.
    Zhou H; Zheng C; Huang DS
    PeerJ; 2020; 8():e9658. PubMed ID: 32844062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.